COVID-19 and Mental Health in Eure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

585 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-13

Study Completion Date

2023-06-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research Hypothesis: Living conditions during COVID-19, and lockdowns and curfews impact the psychological state of patients (assessed by the degree of depression, positive and negative thoughts, insomnia, state of post-traumatic stress).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry

NCT04405362

SARS-CoV 2 Traumatic Stress Disorder

WITHDRAWN

Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population

NCT04397835

COVID-19 Anxiety Depression +1 more

COMPLETED

Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives

NCT04357418

Anxiety State COVID-19 Isolation, Social +1 more

COMPLETED

Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients

NCT01838798

Stress Disorders, Post-Traumatic Depression

COMPLETED NA

Hospital Interns Psychological State During the COVID-19

NCT04669054

COVID 19 Depression Stress Disorders, Post-Traumatic

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

From the early stages of the COVID-19 pandemic, concerns were raised about its effect on mental health and on patients with mental illness. Several surveys and cross-sectional assessments, in Italy, England, Ecuador and China in 2020, have suggested that patients with COVID-19 have symptoms of anxiety (including stress disorder traumatic, depression and insomnia.

In France, a survey by "Santé Publique France" on the impact of COVID-19 on mental health carried out in November 2020, revealed a 20% rate of depressive symptoms in the general population.

The objective of this study is to assess the level of psychological distress and the prevalence of psychiatric disorders related to COVID-19 as part of the follow-up of psychiatric patients in the department of Eure since March 2020, which has coincided with the onset of the health crisis, including consecutive lockdowns and curfews.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Pandemic Psychiatric Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients followed in psychiatry

Quantitative questionnaires

Questionnaires

Intervention Type OTHER

Different questionnaires detailed in the objectives part

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Different questionnaires detailed in the objectives part

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years old
* Coming for a psychiatric consultation or hospitalization at the New Hospital of Navarre or in the extra-hospital centers of the department of Eure
* Patient who has received the information note and who does not refuse to participate in the study

Exclusion Criteria

* Patient not understanding French
* Patient followed in psychiatry for a major cognitive disorder
* Patient under legal protection measure (guardianship, curatorship, safeguard of justice, future protection mandate or family authorization)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No